The Health Sciences Institute is intended to provide cutting-edge health information.
Nothing on this site should be interpreted as personal medical advice. Always consult with your doctor before changing anything related to your healthcare.

For the sake of your liver, ditch these meds now

The study is new… but the sobering facts aren’t.

Recent research out of several UK universities, along with Baylor College of Medicine in Texas, has found a “consistent association” between taking acid-suppressing PPI drugs and developing liver cancer.

This finding comes at the same time the CDC is reporting that the overall death rate for cancer is going down – except for liver cancer, which has gone up during the last 16 years by over 40 percent.

But perhaps the worst part is that the link between cancer and PPIs such as Nexium, Prevacid, and Prilosec isn’t new.

In fact, it was suspected decades ago, even before these meds were approved by the FDA!

Despite those early warnings, however, they’ve gone from carefully controlled Rx drugs to buy-all-you-want OTC versions in an unbelievably short time.

If you’re now taking a PPI, hopefully these findings will be the final straw that convinces you to boot these extremely dangerous meds out of your life for good.

Breaking a ‘taboo’

Of all the risky pharmaceuticals the FDA has approved over the years, there aren’t many that sell as well as proton pump inhibitors – especially since they’ve gone OTC!

Millions of Americans pop some brand of PPI daily. In fact, they’re the most widely used medications on the market.

But before you could find them sitting out on the shelf in most any store – actually even before they landed behind the pharmacy counter, where they required a prescription – there was a worry about these drugs and stomach cancer.

A big worry.

During research with omeprazole (now sold as Prilosec) in the 1980s, tumors turned up in the acid-producing part of the stomach in lab rats. This was a significant finding that slammed the brakes on clinical trials that were going on at the time.

However, in a move that one well-respected gastroenterologist describes as breaking a “taboo” by allowing a drug on the market that caused cancerous tumors in test animals, that finding was brushed aside as only being significant in rats, not humans.

Another study done in rats years later turned up cancer again, this time in the liver.

Now, researchers from the UK and the U.S. have found that people who pop PPIs are at double the risk of developing liver cancer.

And unbelievably, only one other study has even attempted to look for a risk of liver cancer from these drugs in people. It’s like those earlier findings never existed.

Although the scientists behind the new study say that the cause of this deadly association is still not clear, they did mention several possibilities — including one called “hypergastrinemia,” an overproduction of the hormone gastrin, which is known to be caused by long-term PPI use (and also mentioned as a possible factor behind the stomach-cancer findings in the 1980s research).

While gastrin is required for proper digestion, too much, according to the researchers, has been shown “to have a carcinogenic effect,” especially on liver cells.

Another possibility, one very similar to a finding I told you about last year, is that by reducing acid secretion, you’re promoting the “survival of various microbes in the stomach” that are linked to a worsening of liver disease.

As an eAlert reader, you know that we’ve been sounding the alarm about how PPI meds can inflict harm on practically every part of your body, from upping your risk of pneumonia, esophageal cancer, heart attack, and stroke… to zapping your immune function… and setting the stage for a bout with the deadly bacterium C. diff.

Now, we can add liver cancer to that list.

It’s quite obvious that ditching these drugs for good has never been more important. But stopping a PPI can come with its own side effect, one called rebound acid hypersecretion, especially if done too quickly.

That’s why you need to taper your dose down slowly, never stopping cold turkey, which can make your acid problem worse than ever before.

But there are several proven steps you can take to reduce excess stomach acid naturally.

One is to cut back on foods and drinks that are acidic, such as coffee, citrus, tomatoes, and aged cheeses.

Other methods include sipping on a glass of water with an added tablespoon of apple cider vinegar, eating smaller portions of food, dining earlier in the evening, and not lying down right after a meal.

HSI panel member Dr. Glenn Rothfeld also recommends taking a form of licorice called DGL, which comes in tablets meant to be chewed several times a day, and plain old baking soda mixed into water.

Dr. Rothfeld is also a fan of pancreatic digestive enzymes and, if needed, supplemental bile acids that can assist with digestion so your dinner doesn’t come back “to haunt you.”

As I said last year, there are plenty of ways to address excess acid. But when your liver has reached the point of no return, you have very few options.

“Yet another PPI complication: Acid-suppressing drugs and liver cancer?” Joe Graedon, August 9, 2018, The People’s Pharmacy, peoplespharmacy.com

Get a free copy of 5 Household Items that Cause Cancer

By texting HSI to 844-539-1128, you are providing your electronic signature expressly consenting to be called and texted (including by prerecorded messages, using an autodialer, and/or automated means) with alerts, stories, reports, and marketing communications from Institute of Health Sciences, LLC. and its authorized representatives at the phone number you provide, including landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also consent and unconditionally agree to our Privacy Policy and Terms of Use, including the arbitration provision and class action waiver contained therein. Msg&data rates may apply. 15 Msgs/Month. You are not required to agree to this as a condition of making a purchase.

Terms & Conditions

The following Terms and Conditions apply to your use of the website located at hsionline.com (the “website”) and any text messages that you send to or receive from the Institute of Health Sciences, L.L.C. These Terms and Conditions constitute a binding agreement (“Agreement”) between you (“you”) Institute of Health Sciences, L.L.C (“we”, “us”, etc.)  Please read these terms carefully. 

By providing your telephone number to us, texting us a short code listed on the website, or otherwise indicate your agreement to these Terms and Conditions, you are agreeing to the mandatory arbitration provision and class action waiver below. 

ARBITRATION IS MANDATORY AND THE EXCLUSIVE REMEDY FOR ANY AND ALL DISPUTES RELATED TO THIS WEBSITE, THIS AGREEMENT, AND ANY TELEPHONE CALLS, EMAILS, OR TEXT MESSAGES THAT YOU RECEIVE FROM OR ON BEHALF OF US, UNLESS SPECIFIED BELOW OR UNLESS YOU OPT-OUT.

Text Messaging and Telemarketing Terms and Conditions

When you provide your telephone number on this website or send a text message to us with or from a short-code, you agree to receive alerts and communications, and marketing messages including those sent via automated telephone dialing system, text messages, SMS, MMS, and picture messages from Institute of Health Sciences, L.L.C at the phone number you provide on this website or the phone number from which you text the short code, including on landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also agree to the mandatory arbitration provision and class action waiver below. Your consent is not required to purchase goods or services. Message & data rates may apply.

You may opt-out at any time by texting the word STOP to the telephone number from which you receive the text messages.  Call 1-888-213-0764 to learn more.  By providing your telephone number, you agree to notify us of any changes to your telephone number and update your account us to reflect this change. Your carrier may charge you for text messages and telephone calls that you receive, or may prohibit or restrict certain mobile features, and certain mobile features may be incompatible with your carrier or mobile device. Contact your carrier with questions regarding these issues.

Dispute Resolution by Binding Arbitration and Class Action Waiver

Any dispute relating in any way to telephone calls, emails, or text messages that you receive from or on behalf of Institute of Health Sciences, L.L.C this website, or this Agreement (collectively “Disputes”) shall be submitted to confidential arbitration and shall be governed exclusively by the laws of the State of Maryland, excluding its conflict of law provisions.  For the avoidance of doubt, all claims arising under the Telephone Consumer Protection Act and state telemarketing laws shall be considered “Disputes” that are subject to resolution by binding individual, confidential arbitration.

If a Dispute arises under this Agreement, you agree to first contact us at 1-888-213-0764 or help@hsionline.com. Before formally submitting a Dispute to arbitration, you and we may choose to informally resolve the Dispute.  If any Dispute cannot be resolved informally, you agree that any and all Disputes, including the validity of this arbitration clause and class action waiver, shall be submitted to final and binding arbitration before a single arbitrator of the American Arbitration Association (“AAA”) in a location convenient to you or telephonically. Either you or we may commence the arbitration process by submitting a written demand for arbitration with the AAA, and providing a copy to the other party.  The arbitration will be conducted in accordance with the provisions of the AAA’s Commercial Dispute Resolutions Procedures, Supplementary Procedures for Consumer-Related Disputes, in effect at the time of submission of the demand for arbitration.  Except as may be required by law as determined by the arbitrator, no party or arbitrator may disclose the existence, content or results of any arbitration hereunder without the prior written consent of both parties. Institute of Health Sciences, L.L.C will pay all of the filing costs.  Without limiting the foregoing, YOU EXPRESSLY AGREE TO SUBMIT TO ARBITRATION ALL DISPUTES RELATING TO ANY TEXT MESSAGES OR TELEPHONE CALLS YOU RECEIVE FROM OR ON BEHALF OF US OR ANY ENTITY WITH WHOM WE MAY SHARE YOUR TELEPHONE NUMBER.  Further, we both agree that all entities with whom we share your telephone numbers shall be third party beneficiaries of this Agreement to Arbitrate Disputes, and that those entities have the same rights as Institute of Health Sciences, L.L.C to enforce this arbitration provision.

Notwithstanding the foregoing, the following shall not be subject to arbitration and may be adjudicated only in the state and federal courts of Maryland: (i) any dispute, controversy, or claim relating to or contesting the validity of our or one of our family company’s intellectual property rights and proprietary rights, including without limitation, patents, trademarks, service marks, copyrights, or trade secrets; (ii) an action by us for temporary or preliminary injunctive relief, whether prohibitive or mandatory, or other provisional relief; (iii) any legal action by us against a non-consumer; or (iv) interactions with governmental and regulatory authorities.  You expressly agree to refrain from bringing or joining any claims in any representative or class-wide capacity, including but not limited to bringing or joining any claims in any class action or any class-wide arbitration.

The arbitrator’s award shall be binding and may be entered as a judgment in any court of competent jurisdiction. To the fullest extent permitted by applicable law, no arbitration under this Agreement may be joined to an arbitration involving any other party subject to this Agreement, whether through a class action, private attorney general proceeding, class arbitration proceedings or otherwise.

YOU UNDERSTAND THAT YOU WOULD HAVE HAD A RIGHT TO LITIGATE IN A COURT, TO HAVE A JUDGE OR JURY DECIDE YOUR CASE AND TO BE PARTY TO A CLASS OR REPRESENTATIVE ACTION.  HOWEVER, YOU UNDERSTAND AND AGREE TO HAVE ANY CLAIMS DECIDED INDIVIDUALLY AND ONLY THROUGH ARBITRATION.  You shall have thirty (30) days from the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, to opt out of this arbitration agreement, by contacting us by email at help@hsionline.com or by mail Health Sciences Institute, PO Box 913, Frederick, MD 21705-0913. If you do not opt out by the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, then you are not eligible to opt out of this arbitration agreement.

Electronic Signatures

All information communicated on the website is considered an electronic communication.  When you communicate with us through or on the website, by text message or telephone, or via other forms of electronic media, such as e-mail, you are communicating with us electronically.  You agree that we may communicate electronically with you and that such communications, as well as notices, disclosures, agreements, and other communications that we provide to you electronically, are equivalent to communications in writing and shall have the same force and effect as if they were in writing and signed by the party sending the communication.

You further acknowledge and agree that by clicking on a button labeled “ORDER NOW”, “SUBMIT”, “I ACCEPT”, “I AGREE”, “YES”, by texting a short code to us in response to a request on this website, or by clicking or similar links or buttons, you are submitting a legally binding electronic signature and are entering into a legally binding contract.  You acknowledge that your electronic submissions constitute your agreement and intent to be bound by this Agreement.  Pursuant to any applicable statutes, regulations, rules, ordinances or other laws, including without limitation the United States Electronic Signatures in Global and National Commerce Act, P.L. 106-229 (the “E-Sign Act”) or other similar statutes, YOU HEREBY AGREE TO THE USE OF ELECTRONIC SIGNATURES, CONTRACTS, ORDERS AND OTHER RECORDS AND TO ELECTRONIC DELIVERY OF NOTICES, POLICIES AND RECORDS OF TRANSACTIONS INITIATED OR COMPLETED THROUGH THE WEBSITE.  Furthermore, you hereby waive any rights or requirements under any statutes, regulations, rules, ordinances or other laws in any jurisdiction which require an original signature, delivery or retention of non-electronic records, or to payments or the granting of credits by other than electronic means You may receive a physical paper copy of this contract by contacting us at help@hsionline.com.

Privacy Policy

Please read our Privacy Policy, which is incorporated herein by reference.  In the event of any conflict between these Terms and Conditions and the Privacy Policy, these Terms shall control.

Contact Us

You may contact us by telephone at 1-888-213-0764 or by email at help@hsionline.com.